PIPA525450

DOPA Decarboxylase Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA525450-Each-of-1 In Stock ₹ 48,816.50

PIPA525450 - Each of 1

₹ 48,816.50

In Stock

Quantity

1

Base Price: ₹ 48,816.50

GST (18%): ₹ 8,786.97

Total Price: ₹ 57,603.47

Antigen

DOPA Decarboxylase

Classification

Polyclonal

Conjugate

Unconjugated

Gene

DDC

Gene Alias

AADC; aromatic L-amino acid decarboxylase; aromatic-L-amino acid decarboxylase; aromatic-L-amino-acid decarboxylase; DDC; DOPA decarboxylase; dopa decarboxylase (aromatic L-amino acid decarboxylase); HGNC:2719; L-Dopa decarboxylase

Host Species

Rabbit

Purification Method

Antigen affinity chromatography, Protein A

Regulatory Status

RUO

Gene ID (Entrez)

13195, 1644

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot

Concentration

0.5 mg/mL

Formulation

PBS with 0.09% sodium azide

Gene Accession No.

O88533, P20711

Gene Symbols

DDC

Immunogen

KLH conjugated synthetic peptide between 32-61 amino acids from the N-terminal region of human DDC

Quantity

400 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

Ig

Related Products

Img

Thermo Scientific

PIPA525074

--

Img

Thermo Scientific

PIPA524725

--

Img

Thermo Scientific

PIPA526364

--

Img

Thermo Scientific

PIPA526285

--

Img

Thermo Scientific

PIPA526867

--

Img

Thermo Scientific

PIPA524727

--

Img

Thermo Scientific

PIPA526323

--

Img

Thermo Scientific

PIPA526890

--

Description

  • DOPA Decarboxylase (aromatic L-amino acid decarboxylase, AADC; DDC) catalyzes the second reaction in the biosynthesis of catecholamines and serotonin (Waymire and Haycock, 2002; Berry et al., 1996; Haycock et al., 2003)
  • It is also involved in the biosynthesis of trace amines
  • DDC antibodies can therefore be used as markers for dopaminergic, noradrenergic and serotonergic neurons in a variety of applications including depression, schizophrenia, Parkinson's disease and drug abuse (Kish et al., 2001; Zhu et al., 2000; Zhu et al., 1999).